Abstract
Juvenile Rheumatoid Arthritis (JRA) is frequently associated with osteoporosis. In order to determine if JRA osteoporosis is related to reduced formation or to increased bone resorption or both, serum levels of calcium (Ca), phosphorus (PO4), magnesium (Mg), alkaline phosphatase (ALP), parathormone (PTHi), 25-hydroxyvitamin D3 (25-OHD) and 1,25-dihydroxy-vitamin D3 (1,25-(OH)2D), osteocalcin (OT), carboxyterminal propeptide (P-coll-1-c), and carboxyterminal telopeptide of type I collagen (ICTP) were evaluated in 47 JRA children, 33 with active disease and 14 in remission. The therapy consisted of nonsteroidal antiinflammatory (NSAIDs) drugs in pauciarticular subset, NSAIDs and Metothrexate (MTX) in polyarticular, NSAIDs and steroids in systemic onset. OT reflects bone formation, P-coll-1-c reflects collagen production and bone formation, ICTP, marker of collagen degradation in bone, indicates bone destruction. Serum levels of Ca, PO4, Mg, ALP, PTHi 25-OHD and 1,25-(OH)2D were comparable in JRA children and in controls. OT (8.7±3.7 ng/ml vs 9.6±5.1), P-coll-1-c (301.2±118.4 ng/ml vs 264.1±100.1) and ICTP (15.7±5.7 ng/ml vs 16.1±6.1) did not differ statistically in the whole group of JRA children vs controls. OT (8.0±3.5 vs 10.4±3.8) and ICTP (14.4±5.4 vs 18.8±5.4) were significantly lower in active than inactive group. In polyarticular and systemic onset OT and ICTP were significantly lower than in pauciarticular. No difference was found in active patients treated with steroids vs active patients treated with NSAIDS and NSAIDs plus MTX. The lower serum levels of OT and ICTP in active disease support the hypothesis that both bone formation and resorption are reduced in JRA bone turnover.
Similar content being viewed by others
References
Hopp R., Degan J.A., Gallagher J.C., Cassidy J.T. Estimation of bone mineral density in children with juvenile rheumatoid arthritis. J. Rheumatol. 18: 1235, 1991.
Cassidy J.T., Petty R.E. Juvenile rheumatoid arthritis. In: Cassidy J.T., Petty R.E. (Eds.), Textbook of pediatric rheumatology. Churchill Livingstone, New York, 1990, p. 113.
Elsasser U., Wilkins B., Hesp R., Thurnham D.I., Reeve J., Ansell B.M. Bone rarefaction and crush fractures in juvenile chronic arthritis. Arch. Dis. Child. 57: 377, 1982.
Brewer E.J. Jr., Giannini E.H. Standard methodology for segment I, II and III pediatric rheumatology collaborative study group studies. I. Design. J. Rheumatol. 9: 109, 1982.
Giannini E.H., Brewer E.J. Jr. Standard methodology for segment I, II and III pediatric rheumatology collaborative study group studies. II. Analysis and presentation of data. J. Rheumatol. 9: 1144, 1982.
Mundy G.R. Immune system and bone remodelling. Trends Endocrinol. Metab. 1: 307, 1990.
Bouxsein M.L., Marcus R. Overview of exercise and bone mass. Clin. North Am. 20: 787, 1994.
Bacon M.C., White P.H., Raiten D.J. Nutritional status and growth in juvenile rheumatoid arthritis? Semin. Arthrithis Rheum. 20: 97, 1990.
Suskind D., Murthy K.K., Suskind R.M. The malnourished child: an over review. Nestlé Nutrition Workshop Series. Nestec, Ltd. Raven Press, New York, 19: 1, 1990.
Joffe I., Epstein S. Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. Semin. Arthritis Rheum. 20: 256, 1991.
Als O.S., Gotfredsen A., Christiansen C. The effect of glucocorticoids on bone mass in rheumatoid arthritis patients. Arthritis Rheum. 28: 369, 1985.
Reed A., Haughen M., Pachman L.M., Langman C.B. Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases. J. Pediatr. 116: 574, 1990.
Bianchi M.L., Bardare M., Caraceni M.P., Cohen E., Falvella S., Borzani M., De Gaspari M.G. Bone metabolism in juvenile rheumatoid arthritis. Bone Miner. 9: 153, 1990.
Reed A., Haughen M., Pachman LM., Langman CB. 25-hydroxyvitamin D therapy in children with active juvenile rheumatoid arthritis: short-term effects on serum osteocalcin levels and bone mineral density. J. Pediatr. 119: 657, 1991.
Reed A., Haugen M., Pachman L., Langman C. Repair of osteopenia in children with juvenile rheumatoid arthritis. J. Pediatr. 122: 693, 1993.
Hillman L., Cassidy J.T., Johnson L., Lee D., Allen S.H. Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis. J. Pediatr. 124: 9104, 1994.
Pepmueller P.H., Cassidy J.T., Allen S.H., and Hillman L.S. Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid athritis. Arthritis Rheum. 39: 746, 1996.
Cecchettin M., Tarquini B., Manente P., Conte N., Albertini A. Serum osteocalcin assay and its clinical application. In: Cecchettin M., Segre G. (Eds.), Calciotropic hormones and calcium metabolism. Excerpta Medica, Amsterdam, 1986, p 7.
Risteli J., Melkko J., Niemi S., Risteli L. Use of a marker of collagen formation in osteoporosis studies. Calcif. Tissue Int. 49 (Suppl.): 24, 1991.
Risteli J., Niemi S., Elomaa I., Risteli L. Bone resorption assay based on a peptide liberated during type I collagen degradation. J. Bone Miner Res. 6(Suppl 1): S251, 1991.
EULAR standing Committee on Pediatric Rheumatology. Moscow, June 22, 1983.
Nishimoto S.K., Price P.A. Proof that the γ-carboxyglutamic acid-containing bone protein is synthesized in calf bone. J. Biol. Chem. 254: 437, 1979.
Hauschka P.V., Frenkel J., De Muth R., Gundberg C.M. Presence of osteocalcin and related higher molecular weight γ-carboxyglutamic acid-containing proteins in developing bone. J. Biol. Chem. 258: 176, 1983.
Carmel R., Lau K.H.W., Baylink D.J., Saxena S., Singer F.R. Cobalamin and osteoblast-specific proteins. N. Engl. J. Med. 319: 70, 1988.
Falcini F., Trapani S., Civinini R., Capone A., Ermini M., Bartolozzi G. The primary role of steroids on the osteoporosis in juvenile rheumatoid arthritis patients evaluated by dual energy X-ray absorptiometry. J. Endocrinol. Invest. 19: 165, 1996.
Luckert B.P., Higgins J.C., Stoskops M.M. Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J. Clin. Endocrinol. Metab. 62: 1056, 1986.
Sambrook P.N., Eisman J.A., Champion G.D., Yeates M.G., Pocock N.A., Eberl S. Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum. 30: 721, 1987.
Barden H.S., Mazess R.B. Bone densitometry in infants. J. Pediatr. 113: 172, 1988.
Pettipher E.R., Henderson B., Edwards J.C., Higgs G.A. Effect of indomethacin on swelling, lymphocyte influx, and cartilage proteoglycan depletion in experimental arthritis. Ann. Rheum Dis. 48: 623, 1989.
Kikuchi K., Ihn H., Sato S., Igarashi A., Soma Y., Ishibashi Y., Takehara K. Serum concentration of procollagen type I carboxyterminal propeptide in systemic sclerosis. Arch. Dermatol. Res. 286: 77, 1994.
Risteli J., Elomaa I., Niemi S., Novamo A., Risteli L. Radioimmunoassay for the Pyridinoline Cross Linked Carboxy-Terminal Telopeptide of Type 1 Collagen; A new serum marker of bone collagen degradation. Clin. Chem. 39: 635, 1993.
Eriksen E.F., Charles P., Meisen F., Mosekilde L., Risteli L., Risteli J. Serum markers of type 1 collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. Bone Miner. Res. 8: 127, 1993.
Lepore L., Pennesi M., Longo F., Lucchesi A. Serum cytokines levels in polyarticular and in systemic juvenile chronic arthritis. Clin. Exp. Rheumatol. 1: S–9, 1993.
May K.P., West S.G., McDermott M.T., Huffer W.E. The effect of low dose methotrexate on bone metabolism and histomorphometry in rats. Arthritis Rheum. 37: 201, 1994.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Falcini, F., Ermini, M. & Bagnoli, F. Bone turnover is reduced in children with juvenile rheumatoid arthritis. J Endocrinol Invest 21, 31–36 (1998). https://doi.org/10.1007/BF03347283
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347283